Search Results for 'Dabigatran-Vte'

Dabigatran-Vte published presentations and documents on DocSlides.

Dabigatran in Asia RE-LY Asia analysis and real world evidences from Asia
Dabigatran in Asia RE-LY Asia analysis and real world evidences from Asia
by adah
NOAC vs Warfarin Atrial Fibrillation Studies – A...
Dabigatran in  myocardial injury after noncardiac
Dabigatran in myocardial injury after noncardiac
by lois-ondreau
surgery. Dr. PJ Devereaux on behalf of . MANAGE I...
DentalUpdateNovember 2015A New Generation of Antiplatelet and Anticoag
DentalUpdateNovember 2015A New Generation of Antiplatelet and Anticoag
by cecilia
Steven Johnston, BDS, MSc, MFDS RCS(Ed), Dental Of...
NOACs vs. warfarin:  Pros and Cons for Patients and Providers to Consider
NOACs vs. warfarin: Pros and Cons for Patients and Providers to Consider
by debby-jeon
Advantages of NOACs. No INR monitoring required. ...
New Oral Anticoagulants: A    Review
New Oral Anticoagulants: A Review
by phoebe-click
Babak Moini, MD. Veterans Affairs Hospital. Noon ...
A New Era in Anticoagulation Management
A New Era in Anticoagulation Management
by alexa-scheidler
Allyson Sarigianis, Pharm.D.. October 19, 2013. O...
Stroke, Bleeding, and
Stroke, Bleeding, and
by lois-ondreau
Mortality Risks . in . Elderly Medicare Beneficia...
Safety and Efficacy of Uninterrupted Anticoagulation with
Safety and Efficacy of Uninterrupted Anticoagulation with
by olivia-moreira
Dabigatran . Etexilate versus Warfarin in Patient...
The Novel Oral Anticoagulants
The Novel Oral Anticoagulants
by tatyana-admore
Fawaz Altuwaijri. ACEM trainee. Introduction. Cha...
New Oral Anticoagulant
New Oral Anticoagulant
by mitsue-stanley
R2 Patcharee Seesongsom. R2 . Sirada. . Phoja...
A New Era in Anticoagulation Management
A New Era in Anticoagulation Management
by debby-jeon
Allyson Sarigianis, Pharm.D.. October 19, 2013. O...
Novel Oral Anticoagulants
Novel Oral Anticoagulants
by natalia-silvester
(. N. OAC). Dan . Moellentin. , . PharmD. , BCPS,...
Management of
Management of
by marina-yarberry
Atrial. Fibrillation. Phillip H. Lam, M.D.. Chie...
Thromboembolic protocols
Thromboembolic protocols
by cecilia
& safe anticoagulant prescribing. July 2020. D...
John Hanley
John Hanley
by eve
Consultant HaematologistNewcastle Hospitals NHS Tr...
wvwvyzwvxv
wvwvyzwvxv
by eddey
coronary intervention PCI1920 As new antithromboti...
Nonvalvular Atrial Fibrillation Anticoagulation Colour Comparison Ch
Nonvalvular Atrial Fibrillation Anticoagulation Colour Comparison Ch
by daniella
www.RxFiles.ca June 2021 Drug / BRAND Vitamin K ...
OHDSI  estimation-methods papers in progress
OHDSI estimation-methods papers in progress
by impristic
Martijn Schuemie, PhD. Janssen Research and Develo...
Pharmacology of Anticoagulants
Pharmacology of Anticoagulants
by conchita-marotz
Nathan Culver, . PharmD. , BCPS. anticoagulant Me...
POWER IN NUMBERS: REVISITING EFFICACY & SAFETY OF
POWER IN NUMBERS: REVISITING EFFICACY & SAFETY OF
by phoebe-click
NOACS IN AF. Where Do We Stand With NOACs in AF ...
Journal Club Jim Hoehns,
Journal Club Jim Hoehns,
by cheryl-pisano
Pharm.D. .. Edoxaban. Oral factor . Xa. inhibito...
The direct oral anticoagulants (DOACs)
The direct oral anticoagulants (DOACs)
by faustina-dinatale
and major trauma. Dr. Tina . Biss. Consultant . ...
ANTICOAGULATION Blake  Wachter
ANTICOAGULATION Blake Wachter
by olivia-moreira
, MD, PhD . Monday Morning Conference. Oct 4, 201...
An Update on Reversal Agents for NOACs: Where Are
An Update on Reversal Agents for NOACs: Where Are
by briana-ranney
We Now?. Moderator. Christian T. Ruff, MD, MPH. A...
Oral anticoagulants in the 21
Oral anticoagulants in the 21
by natalia-silvester
st. century: A practical guide to using newer A...
Concomitant Antiplatelet and OAC
Concomitant Antiplatelet and OAC
by kittie-lecroy
Tx. : . Real-World Practice. In the US, ~800,000 ...